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NPY2R signaling gates spontaneous
and mechanical, but not thermal,
pain transmission
Sihan Chen1,2,3, Xian-Yu Liu2,3 , Yingfu Jiao1,
Zhou-Feng Chen2,3,4,5 and Weifeng Yu1
Abstract
Neuropeptide Y signaling plays an important role in inhibiting chronic pain in the spinal cord of mice. However, little is
known about the respective roles of two major neuropeptide Y receptors, Y1R and Y2R, in evoked and spontaneous pain
behavior under normal physiological condition. Using intrathecal administration approach, we found that pharmacological
inhibition of Y2R, unexpectedly, gave rise to spontaneous pain behavior. In addition, Y2R antagonism also resulted in long-
lasting mechanical but not thermal hypersensitivity. By contrast, neither overt spontaneous pain behavior nor mechanical and
thermal hypersensitivity were detected after pharmacological inhibition of Y1R. Remarkably, the activation of Y1R produced
powerful analgesic effect: blocking both evoked and spontaneous pain behavior resulted from Y2R antagonism. These
findings highlight the pivotal role of endogenous Y2R in gating mechanical and spontaneous pain transmission.
Importantly, our results suggest that Y1R could be a therapeutic target that may be exploited for alleviating spontaneous
pain without affecting acute pain transmission.
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Introduction
Spinal nociceptive transmission involves a wide variety
of neuropeptides and transmitters. Neuropeptide Y
(NPY), a 36-amino acid peptide, is a major signaling
peptide that inhibits nociceptive and itch transmis-
sion.1–4 NPY receptor family comprises five members
in mammals with relative low sequence similarity.4
NPY is barely detectable in sensory neurons, but present
in GABAergic neurons of the spinal cord.5–9 In the
dorsal root ganglion (DRG) neurons and the spinal
cord, major NPY receptors identified are Y1R and
Y2R, two Gi/o protein-coupled receptors (GPCRs)
whose activation results in inhibition of chronic pain
transmission.3,10 Y2R is expressed in a subset of
medium- and large-size peptidergic A-fiber nociceptors,
which peripherally innervate hairy and glabrous skin
and centrally lamina II of the spinal cord.10,11 In con-
trast, Y1R is expressed in small-diameter nociceptors in
DRGs,11 and in somatostatin (SOM)-positive excitatory
interneurons in laminae I–II of the spinal cord.6,12,13
Y1R mRNA or Y1R signaling is upregulated in DRG
neurons and the spinal cord under inflammatory and
1Department of Anesthesiology, Ren Ji Hospital, School of Medicine,
Shanghai Jiao Tong University, Shanghai, P.R. China
2Center for the Study of Itch, Washington University School of Medicine,
St. Louis, MO, USA
3Department of Anesthesiology, Washington University School of
Medicine, St. Louis, MO, USA
4Department of Psychiatry, Washington University School of Medicine,
St. Louis, MO, USA
5Department of Developmental Biology, Washington University School of
Medicine, St. Louis, MO, USA
Corresponding Authors:
Zhou-Feng Chen, Washington University in Saint Louis, 660 S. Euclid
Avenue, Saint Louis, MO 63110, USA.
Email: chenz@wustl.edu
Weifeng Yu, Department of Anesthesiology, Ren Ji Hospital, School of









Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-
NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and dis-
tribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.
sagepub.com/en-us/nam/open-access-at-sage).
neuropathic pain conditions in rodents.5,14,15 Intrathecal
(i.t.) activation of Y1R has been shown to inhibit both
chemical and mechanical itch16,17 as well as mechanical
and cold allodynia in neuropathic pain models.18 The
NPY receptor system is important for tonic inhibition
of inflammatory and neuropathic pain.19
Although numerous studies using i.t. administration
of NPY have suggested an important role of NPY sig-
naling in pain transmission, the respective role of Y1R
or Y2R is unclear. Moreover, prior research on Y2R
signaling has relied on mechanical and thermal stimuli-
evoked reflex measurement in the setting of chronic
pain conditions, leaving its function in gating pain trans-
mission under normal physiological condition
undetermined. Using highly selective Y2R and Y1R
antagonists, the present study aims to determine the
function of Y1R and Y2R in nociceptive transmission
under normal physiological condition.
Materials and methods
Animals
Experiments were carried out on 7- to 12-week-old male
C57BL/6J mice (Jackson Labs, Sacramento, CA). All
mice were housed in clear plastic cages with no more
than five mice per cage in a controlled environment at
a constant temperature of 23C and humidity of 50
10% with a light–dark cycle of 12 h–12 h. The animals
had food and water available ad libitum. All experiments
conform to guidelines set by the National Institutes of
Health and the International Association for the Study
of Pain and were reviewed and approved by the
Institutional Animal Care and Use Committee at
Washington University School of Medicine. All the
efforts were made to minimize animal suffering and to
reduce the number of animals used.
Drugs
Y2R antagonist BIIE0246, Y1R antagonist BIBO3304,
and Y1R agonist LP-NPY were purchased from Tocris
(MN, USA). GRP18-27 was from Bachem (CA, USA).
Morphine was from Hospira (IL, USA). BIIE0246 and
BIBO3304 were first dissolved in dimethylsulfoxide and
then diluted in sterile saline for injections. LP-NPY and
gastrin-releasing peptide (GRP) were dissolved in sterile
saline.
Acute scratching behavior
I.t. injections and acute scratching behaviors were per-
formed as previously described.20,21 Briefly, the caudal
paralumbar region of the mice was shaved at least three -
days before experiments. Mice were placed in a plastic
box (10 11 15 cm) for 30min per day to acclimate for
three days. On the testing day, mice were given 15min to
acclimate in the box prior to i.t. injections using a
30-gauge needle inserting into the fifth intervertebral
space. The injection volume was 10 ll. Mice were
returned to the box and the behaviors were videotaped
from a side angle. An observer blinded to the treatments
of mice quantified the number of scratching behaviors.
One scratch is defined as a lifting of the hind limb
toward the body and then a shifting of the limb to the
mouth or back to the floor, regardless of how many
scratching strokes take place between those two
movements.
Rotarod test
A rotarod system of accelerating treadmills was used
to assess coordinate motor activity and general
motor disability as described.22 Mice were trained to
maintain its belaying walking on a rotarod apparatus
at five revolution per minute (r/min) for 5min on the
first two days. On the third day, mice received i.t. injec-
tions of BIIE0246 or LP-NPY. Two hours after
BIIE0246 injection or 15min after LP-NPY injection,
the mice were tested for three trials at accelerating
speed (5–40 r/min) with 15-min intervals. The latencies
of mice to fall off were recorded for analysis. The cut-off
time was 300 s.
Acute pain behavior tests
Mice were habituated to the wire mash 1 h per day for
three days before the test. Mechanical sensitivity was
assessed using a set of calibrated von Frey filaments
(North Coast, CA, USA). Each filament was applied
five consecutive times with 10-s intervals and the smallest
filament that evoked reflexive flinches of the hindpaw on
three of five trials was taken as paw withdrawal
threshold.
Thermal sensitivity was determined using a
Hargreaves apparatus. The hindpaw withdrawal latency
to a beam of radiant heat was measured three times with
10-min intervals and averaged for analysis.
Statistical analysis
All the data were presented as means standard error of
the mean. Statistical tests are indicated in figure legends.
Two-tailed, unpaired Student’s t test was used for two-
group comparisons. One-way analysis of variance
(ANOVA) with Tukey’s post hoc was used for the com-
parisons of more than two groups. Two-way ANOVA
with Tukey’s post hoc was used for multiple elements
comparisons. Statistical analyses were performed using
Prism 7 (v7.0c, GraphPad, San Diego, CA). Normality
and equal variance tests were performed for all statistical
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analyses. A value of p< 0.05 was considered statistically
significant.
Results
Pharmacological inhibition of Y2R in the spinal cord
induces spontaneous pain behavior
To examine the role of Y2R in nociceptive transmission
under normal physiological condition, we tested
the effect of a highly selective and potent Y2R
antagonist, BIIE0246 (thereafter referred to as BIIE),23
by i.t. injection of BIIE into wild-type C57 mice.
At 0.1 lg, no overt behavior was observed within
30min (Figure 1(a)). At 0.5lg, mice exhibited slightly
increased scratching behavior, but not statistically sig-
nificant as compared to the saline control (Figure 1(a)).
However, significant increase of scratching behavior was
detected at 1 lg and 5lg, (Figure 1(a)). To ascertain
whether inhibition of Y2R-induced spontaneous
scratching behavior reflects itch or pain, we tested
the effect of i.t. morphine (0.3 nmol) on BIIE-ineduced
scratching behavior. Gastrin-releasing peptide receptor
(GRPR) is a Gq protein-coupled receptor expressed in
the spinal cord and is important for mediating nonhis-
taminergic itch transmission.20,21,24 I.t. GRP-induced
scratching behavior and morphine-mediated analgesia
are mediated through distinct molecular and neural
pathways in the spinal cord.25,26 While morphine failed
to inhibit GRP-induced scratching behavior, it signifi-
cantly attenuated spontaneous scratching behavior
induced by BIIE (Figure 1(b)). These data suggested
that BIIE treatment resulted in spontaneous pain behav-
ior, manifested in pain-related scratching behavior, and
the effect was mediated by Y2R because it was dose
dependent.
Pharmacological inhibition of Y2R in the spinal cord
induces mechanical allodynia which could be inhibited
by morphine
To examine whether BIIE treatment may affect the
motor function of mice, we examined mouse behaviors
using the rotarod test after i.t. injections of a series of
dose of BIIE. For the mice treated with BIIE up to 1 lg,
no major difference in the fall off latencies was observed
(Figure 2). However, BIIE at 5 lg severely blunted the
rotarod test (Figure 2). To test the effect of BIIE on
acute mechanical sensitivity, we examined the threshold
of evoked hindpaw withdrawal responses using von Frey
test. Remarkably, BIIE at 0.1 lg showed significantly
reduced withdrawal threshold, which lasted for at least
6 h, as compared to the saline control (Figure 3(a)).
Interestingly, there was no major difference in the
threshold of evoked paw withdrawal responses between
0.1, 0.5, and 1 lg (Figure 3(a)), indicating that BIIE has
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Figure 1. Inhibition of Y2R in the spinal cord induced pain-related scratching behaviors. (a) I.t. injections of Y2R antagonist, BIIE (0.1lg,
0.5 lg, 1 lg, and 5 lg), induced dose-dependent scratching behaviors. n¼ 6 mice per group. *p< 0.05, ***p< 0.001, one-way ANOVA with
Tukey’s post hoc tests. (b) Preinjection of morphine (0.3 nmol, i.t.) for 30min inhibited the scratching behaviors induced by i.t. injection of
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Figure 2. High dose of Y2R antagonist impaired motor function.
I.t. injection of BIIE at 5lg significantly decreased the fall off
latencies in rotarod test compared with saline and low doses of
BIIE (0.1 lg, 0.5 lg and 1lg). n¼ 6 mice per group. ***p< 0.001,
one-way ANOVA with Tukey’s post hoc test.
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reached the ceiling effect at 0.1lg. Next, we examined
the thermal pain behavior of these mice treated with
BIIE using Hargreaves test and found no significant dif-
ference in the thermal sensitivity compared to the saline
control (Figure 3(b)). We also examined whether acute
mechanical pain could be reversed by morphine and
found that coinjection of morphine significantly attenu-
ated BIIE-induced mechanical hypersensitivities at the
first 2 h (Figure 3(c)). The lack of analgesia effect of
morphine at late phase could be attributable to wear
off the drug.
Pharmacological activation of Y1R in the spinal cord
reverses mechanical allodynia induced by BIIE
To examine the relationship between the Y1R and Y2R,
we first tested whether the activation of Y1R could
inhibit spontaneous pain behavior unmasked by Y2R
antagonism. Strikingly, following i.t. administration of
a highly selective Y1R agonist, LP-NPY (1 nmol),27 no
spontaneous pain behavior was detected as a result of
BIIE administration (Figure 4(a)). These results suggest
that Y1R activation, or inhibition of Y1R neurons,
precludes spontaneous pain transmission as a result
from Y2R antagonism. Next, we tested whether the acti-
vation of Y1R could reverse mechanical allodynia
following BIIE administration or Y2R antagonism.
Remarkably, i.t. LP-NPY treatment not only block the
effect of BIIE but further increased the mechanical
threshold up to around 3 g and 2.5 g after injection
30min and 1 h, respectively (Figure 4(b)). Importantly,
mice received LP-NPY injections were apparently
normal and the fall off latencies on rotarod were com-
parable between LP-NPY group and saline group
(Figure 4(c)). Thus, pharmacological activation of
Y1R, or inhibition of Y1R neurons, could result in
potent analgesic effect stronger than either i.t. morphine
(Figure 3(c)) or ablation of spinal SOM neurons.28
Pharmacological inhibition of Y1R in the spinal
cord does not induce spontaneous, tactile, or
thermal pain behavior
Lastly, we investigated whether inactivation of Y1R may
alter nociceptive transmission by i.t. administration of
BIBO 330429 (thereafter referred to as BIBO), a highly
selective Y1R antagonist that can significantly reinstate
mechanical and thermal hypersensitivity of mice with
chronic pain.19 In contrast to BIIE, BIBO had no signif-
icant effect on spontaneous scratching behavior
compared to the control (Figure 5(a)). However, pre-
treatment of BIBO (1mg) increased the spontaneous
pain behavior inhibited by LP-NPY in BIIE-treated
mice (Figure 5(b)). I.t. BIBO (1mg) also failed to alter
mechanical and thermal sensitivities under normal phys-
iological condition (Figure 5(c) and (d)), a finding con-
sistent with the previous study.19
Discussion
The present study shows that Y2R is a pivotal inhibitory
GPCR that gates the nociceptive transmission under
normal physiological condition. There are two distinct
aspects of Y2R function in gating nociceptive transmis-
sion. First, pharmacological inhibition of Y2R results in
disinhibition of nociceptive transmission, which mani-
fests in spontaneous pain behaviors. This indicates that
the endogenous NPY-Y2R signaling pathway exerts
powerful tonic inhibition of nociceptive circuitry at the
spinal level under normal physiological condition. To
the best of our knowledge, this is the first description
of spontaneous pain behavior after inhibition of a
GPCR in the spinal cord under normal physiological
condition. Second, the finding that pharmacological
inhibition of Y2R activity causes mechanical but not
thermal hypersensitivity uncovers a unique role of
Y2R signaling in gating mechanical pain, under
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Figure 3. Inhibition of Y2R in the spinal cord induced mechanical
allodynia. Von Frey test (a) and Hargraves test (b) showed that i.t.
injections of BIIE at 0.1lg, 0.5 lg, or 1 lg significantly decreased
the mechanical pain threshold for at least 6 h (a), while thermal
pain sensitivity was not affected (b). n¼ 6–8 mice per group,
***p< 0.001, two-way ANOVA with Tukey’s post hoc test.
(c) Coinjection of morphine (0.3 nmol) significantly blocked
0.1 lg BIIE-induced mechanical hypersensitivity for the first 2 h.
n¼ 6–8 mice per group. **p< 0.01, ***p< 0.001, two-way
ANOVA with Tukey’s post hoc test.
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shown that the delta opioid receptor (DOR) and mu
opioid receptor (MOR) regulate mechanical and thermal
hypersensitivity in DRGs and spinal cord, respective-
ly.30,31 DOR is expressed in myelinated nonpeptidergic
fibers, whereas MOR in small peptidergic pain fibers.31
Our observation of the selective involvement of Y2R in
mechanical but not thermal pain is reminiscent of the
role of DOR. Interestingly, DOR is expressed in spinal
SOMþ neurons that gate mechanical but not thermal
pain.28,30 Therefore, it will be of interest to determine
whether Y2R is coexpressed with DOR or marks distinct
subset of dorsal horn neurons in future studies. It is
possible that Y2R neurons are integral part of the micro-
circuits that gate mechanical pain. Combined with the
important role of Y2R in the development and mainte-
nance of inflammatory and neuropathic pain,19 Y2R has
emerged as a key player in regulating spontaneous, acute
mechanical, and chronic pain transmission.
Because Y2R is expressed in both DRGs and the
spinal cord,10,11 the action site of BIIE remains unclear.
However, given NPY is not detectable in DRGs,32,33
endogenous spinal NPY is likely to be a major source
for targeting spinal Y2R rather than presynaptic Y2R.
By contrast, Y2R in DRGs may function peripherally
rather than centrally.10 Recently, Arcourt et al. showed
that the activation of peripheral Y2R fibers induces
mechanical pain,10 raising the possibility that Y2R
may have similar function both peripherally and
centrally. It will be of interest to determine whether
peripheral Y2R may be dedicated to gating nociceptive
transmission.
Our finding reveals distinct roles of Y2R and Y1R in
nociceptive transmission. Unlike Y2R, Y1R is dispens-
able for gating spontaneous pain and mechanical pain.
On the other hand, the observation that the activation of
Y1R neurons could block spontaneous and mechanical
pain unmasked by disinhibition of Y2R neurons implies
that Y1R neurons nevertheless function downstream of
Y2R neurons. This suggests that additional inhibitory
signaling mechanisms are likely to work in concert in
Y1R neurons to gate nociceptive transmission. Indeed,
that inhibition of Y1R neurons by pharmacological acti-
vation of Y1R resulted in analgesic effect more potent
than either i.t. morphine or ablation of spinal SOM neu-
rons28 is in support of this notion. Nevertheless, one
should be cautious when inferring the endogenous role
of a GPCR from behavior resulted from pharmacolog-
ical activation.
One interesting observation is that depending on the
behavioral tests, the same dose of BIIE may have dis-
crete effects. For example, while i.t. 5 lg is too high for
mice to endure rotarod test, it does not preclude mice
from performing hindlimb-directed pain-related scratch-
ing behavior. It is also interesting that while the ceiling
effect on acute mechanical allodynia was observed at
0.1 lg, this dose is insufficient to cause spontaneous






















































Figure 4. The activation of Y1R in the spinal cord alleviated BIIE-induced pain behaviors. (a) Coinjection of Y1R agonist, LP-NPY (1 nmol)
significantly decreased scratching behavior induced by BIIE (5 lg) treatment. n¼ 6 mice per group. ***p< 0.001, unpaired t test. (b)
Coinjection of LP-NPY (1 nmol) reversed mechanical hypersensitivity induced by BIIE (0.1 lg) treatment for 1 h. n¼ 6 mice per group.
***p< 0.001, two-way ANOVA with Tukey’s post hoc test. (c) I.t. injection of LP-NPY (1 nmol) did not affect the fall off latencies in rotarod
test compared with saline group. n¼ 6 mice per group. ns: not significant, unpaired t test.
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pain behavior. Nevertheless, the data point to a much
more potent inhibition of Y2R for breaking the gate to
enable spontaneous than mechanical pain transmission.
Elucidation of spinal inhibitory neuropeptide recep-
tor signaling mechanisms by which nociceptive transmis-
sion is gated in the spinal cord has been technically
challenging for several reasons. First, a conventional
or even conditional knockout of a peptide or receptor
approach always risks developmental compensatory
effect when no overt phenotype is detected. Second,
pharmacological manipulation of GPCR is of limited
use because highly selective antagonists/agonists are
often not available for many GPCRs. By taking advan-
tage of highly specific antagonists for Y1/2R and agonist
for Y1R, we are able to dissect the respective roles of
Y2R and Y1R in gating nociceptive transmission under
physiological condition. While Y2R is a pivotal receptor
that gates spontaneous and mechanical pain, Y1R may
be a preferred therapeutic target that could be harnessed
for alleviating spontaneous and mechanical pain without
impacting acute pain transmission.
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